Cargando…

Histopathological Evaluation of Heart Toxicity of a Novel Selective PPAR-γ Agonists CKD-501 in db/db Mice

High risk of cardiovascular diseases caused by existing PPAR-γ agonists such as rosiglitazone and pioglitazone has been recently reported. CKD-501 is a novel selective PPAR-γ agonist as a potential target to reduce cardiovascular risk in non-insulin dependent diabetes mellitus (NIDDM). In this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hyun-Il, Kim, Woo Sik, Kim, Dal-Hyun, Kang, Jin Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Applied Pharmacology 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762307/
https://www.ncbi.nlm.nih.gov/pubmed/24009864
http://dx.doi.org/10.4062/biomolther.2012.101

Ejemplares similares